➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Medtronic
Moodys
McKinsey
Express Scripts
Harvard Business School

Last Updated: June 19, 2021

DrugPatentWatch Database Preview

KEFLEX Drug Profile


Email this page to a colleague

« Back to Dashboard

When do Keflex patents expire, and when can generic versions of Keflex launch?

Keflex is a drug marketed by Pragma and is included in two NDAs.

The generic ingredient in KEFLEX is cephalexin. There are twenty-nine drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the cephalexin profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Keflex

A generic version of KEFLEX was approved as cephalexin by TEVA on February 13th, 1987.

  Get Started Free

Drug patent expirations by year for KEFLEX
Drug Prices for KEFLEX

See drug prices for KEFLEX

Drug Sales Revenue Trends for KEFLEX

See drug sales revenues for KEFLEX

Recent Clinical Trials for KEFLEX

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of California, Los AngelesPhase 4
University of IowaPhase 4
University of Colorado, DenverPhase 1

See all KEFLEX clinical trials

Pharmacology for KEFLEX

US Patents and Regulatory Information for KEFLEX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pragma KEFLEX cephalexin CAPSULE;ORAL 050405-002 Approved Prior to Jan 1, 1982 AB RX Yes No   Get Started Free   Get Started Free   Get Started Free
Pragma KEFLEX cephalexin FOR SUSPENSION;ORAL 050406-002 Approved Prior to Jan 1, 1982 DISCN Yes No   Get Started Free   Get Started Free   Get Started Free
Pragma KEFLEX cephalexin CAPSULE;ORAL 050405-005 May 12, 2006 AB RX Yes Yes   Get Started Free   Get Started Free   Get Started Free
Pragma KEFLEX cephalexin CAPSULE;ORAL 050405-004 May 12, 2006 DISCN Yes No   Get Started Free   Get Started Free   Get Started Free
Pragma KEFLEX cephalexin CAPSULE;ORAL 050405-003 Approved Prior to Jan 1, 1982 AB RX Yes No   Get Started Free   Get Started Free   Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Harvard Business School
Medtronic
Dow
Baxter
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.